Patent · US Active

Live, attenuated vaccines and methods of making and using

US10322172B2 · kind B2 · utility

0Cited by
1References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 10, 2015
Grant dateJun 18, 2019
Priority date
Expiry dateFeb 10, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2740/16234
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A live, attenuated HIV vaccine is provided, and methods of making a attenuated HIV vaccine are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.